| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 783 | 12,039 | 9,815 | 16,979 | | Cost of Revenue | 166 | 8,890 | 8,115 | 11,947 | | | Gross Profit | 617 | 3,149 | 1,700 | 5,032 | | | Operating Expenses | | Research Development | 171 | 2,840 | 3,163 | 2,943 | | Selling General and Administrative | 1,472 | 2,821 | 3,547 | 3,200 | | Non Recurring | (16) | 1,249 | 6,161 |
-
| | Others |
-
|
-
| 179 | 179 | | | | Total Operating Expenses |
-
|
-
| 13,050 |
-
| | | | Operating Income or Loss | (1,010) | (3,761) | (11,350) | (1,290) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 107 | 93 | 206 | 291 | | Earnings Before Interest And Taxes | (903) | (3,668) | (11,144) | (999) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (903) | (3,668) | (11,144) | (999) | | Income Tax Expense | (13) | (8) | (88) |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (890) | (3,660) | (11,056) | (999) | | | Non-recurring Events | | Discontinued Operations | 17,530 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 16,640 | (3,660) | (11,056) | (999) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $16,640 | ($3,660) | ($11,056) | ($999) |
|
0.20% Nasdaq 
0.14%
Income Statement
